DK1210325T3 - Aminobenzofenoner som inhibitorer for IL-1beta og TNF-alfa - Google Patents

Aminobenzofenoner som inhibitorer for IL-1beta og TNF-alfa

Info

Publication number
DK1210325T3
DK1210325T3 DK00943701T DK00943701T DK1210325T3 DK 1210325 T3 DK1210325 T3 DK 1210325T3 DK 00943701 T DK00943701 T DK 00943701T DK 00943701 T DK00943701 T DK 00943701T DK 1210325 T3 DK1210325 T3 DK 1210325T3
Authority
DK
Denmark
Prior art keywords
substituent
alkyl
group
carbamoyl
alkoxycarbonyl
Prior art date
Application number
DK00943701T
Other languages
Danish (da)
English (en)
Inventor
Erik Rytter Ottosen
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Application granted granted Critical
Publication of DK1210325T3 publication Critical patent/DK1210325T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/60—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • AIDS & HIV (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00943701T 1999-07-16 2000-07-11 Aminobenzofenoner som inhibitorer for IL-1beta og TNF-alfa DK1210325T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14406299P 1999-07-16 1999-07-16
PCT/DK2000/000387 WO2001005751A1 (fr) 1999-07-16 2000-07-11 AMINOBENZOPHENONES, INHIITEURS DE L'INTERLEUKINE IL-β ET DU FACTEUR TNF-$g(a)
EP00943701A EP1210325B1 (fr) 1999-07-16 2000-07-11 Aminobenzophenones, inhiiteurs de l'interleukine il-beta et du facteur tnf-alpha

Publications (1)

Publication Number Publication Date
DK1210325T3 true DK1210325T3 (da) 2005-01-31

Family

ID=22506888

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00943701T DK1210325T3 (da) 1999-07-16 2000-07-11 Aminobenzofenoner som inhibitorer for IL-1beta og TNF-alfa

Country Status (18)

Country Link
US (1) US6750253B1 (fr)
EP (1) EP1210325B1 (fr)
JP (1) JP2003505363A (fr)
KR (1) KR20020033733A (fr)
CN (1) CN1249025C (fr)
AT (1) ATE278663T1 (fr)
AU (1) AU768878B2 (fr)
CA (1) CA2379293A1 (fr)
CZ (1) CZ2002157A3 (fr)
DE (1) DE60014681T2 (fr)
DK (1) DK1210325T3 (fr)
ES (1) ES2228556T3 (fr)
HK (1) HK1048464B (fr)
HU (1) HUP0201913A3 (fr)
PL (1) PL353644A1 (fr)
PT (1) PT1210325E (fr)
RU (1) RU2247719C2 (fr)
WO (1) WO2001005751A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0301932A3 (en) 2000-05-22 2007-09-28 Leo Pharma As Benzophenones as inhibitors of il-1 beta and tnf-alpha, pharmaceutical compositions containing them and use of them for producing pharmaceutical compositions
CA2458611C (fr) * 2001-08-28 2012-05-29 Leo Pharma A/S Aminobenzophenones en tant qu'inhibiteurs de l'interleukine-1 beta et du facteur de necrose tumorale-alpha
US20030225089A1 (en) * 2002-04-10 2003-12-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
ATE349210T1 (de) 2002-07-09 2007-01-15 Boehringer Ingelheim Pharma Pharazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege
PT1658263E (pt) * 2003-07-24 2010-09-06 Leo Pharma As Novos compostos de aminobenzofenona
US20060035893A1 (en) 2004-08-07 2006-02-16 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
CA2590479A1 (fr) 2004-12-13 2006-06-22 Leo Pharma A/S Derives d'aminobenzophenone substitues par un triazole
PE20060777A1 (es) 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
SI2719388T1 (sl) * 2006-02-16 2019-06-28 Anacor Pharmaceuticals, Inc. Majhne molekule, polnjene z borom, kot učinkovine proti vnetjem
RU2486914C2 (ru) * 2006-03-16 2013-07-10 Молеак Пте Лтд Комбинированная терапия для лечения пациентов с неврологическими нарушениями и церебральным инфарктом
EP1992344A1 (fr) 2007-05-18 2008-11-19 Institut Curie P38 alpha comme cible therapeutique pour les maladies associées á une mutation de FGFR3
EP2206534A1 (fr) 2008-10-09 2010-07-14 c-a-i-r biosciences GmbH Dérivés de dibenzocycloheptanone et produits pharmaceutiques comprenant ces composés
KR100984851B1 (ko) * 2009-02-05 2010-10-04 주식회사 엠에스엠텍 램프이탈방지형 엘이디 조명
US8912184B1 (en) 2010-03-01 2014-12-16 Alzheimer's Institute Of America, Inc. Therapeutic and diagnostic methods
US10684274B2 (en) 2016-01-12 2020-06-16 The George Washington University, A Congressionlly Chartered Not-For-Profit Corporation Compounds inhibiting Nef-calnexin interaction

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9701453D0 (en) * 1997-01-24 1997-03-12 Leo Pharm Prod Ltd Aminobenzophenones

Also Published As

Publication number Publication date
HUP0201913A2 (en) 2002-10-28
CZ2002157A3 (cs) 2002-08-14
ES2228556T3 (es) 2005-04-16
PT1210325E (pt) 2005-01-31
HUP0201913A3 (en) 2002-11-28
RU2247719C2 (ru) 2005-03-10
PL353644A1 (en) 2003-12-01
WO2001005751A1 (fr) 2001-01-25
AU5807000A (en) 2001-02-05
CN1249025C (zh) 2006-04-05
HK1048464A1 (en) 2003-04-04
US6750253B1 (en) 2004-06-15
CN1368957A (zh) 2002-09-11
HK1048464B (zh) 2006-09-01
EP1210325A1 (fr) 2002-06-05
DE60014681D1 (de) 2004-11-11
DE60014681T2 (de) 2006-02-02
ATE278663T1 (de) 2004-10-15
JP2003505363A (ja) 2003-02-12
AU768878B2 (en) 2004-01-08
KR20020033733A (ko) 2002-05-07
CA2379293A1 (fr) 2001-01-25
EP1210325B1 (fr) 2004-10-06

Similar Documents

Publication Publication Date Title
DK1210325T3 (da) Aminobenzofenoner som inhibitorer for IL-1beta og TNF-alfa
DK1202957T3 (da) Aminobenzofenoner som inhibitorer for IL-1beta og TNF-alfa
ATE362912T1 (de) Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
PE20060525A1 (es) Compuestos heterociclicos como inhibidores de cetp
MY151455A (en) Carbonylamino pyrrolopyrazoles, potent kinase inhibitors
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
ECSP066886A (es) Compuestos y métodos para el tratamiento de dislipidemia
DK1663242T3 (da) 2,4-Pyrimidindiamin-forbindelser og anvendelse som antiproliferative midler
MX2007004781A (es) Derivados de 3-arilamino piridina.
TW200700422A (en) Compounds for inhibiting ksp kinesin activity
NO20044995L (no) Heterosykliske forbindelser
DK1268471T3 (da) N-heterocykliske derivater som NOS-inhibitorer
TW200700066A (en) Compounds for inhibiting ksp kinesin activity
DK1641803T3 (da) Thienopyrimidinderivater som kaliumkanalinhibitorer
DK1210320T3 (da) Aminobenzofenoner som inhibitorer for IL-1beta og TNF-alfa
RS50781B (sr) Derivati pirido (2,3-d) pirimidina, njihovo dobijanje, njihova primena u terapiji
ATE277897T1 (de) Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
DE60204701D1 (de) Tricyclische imidazopyridine
DK1373220T3 (da) Benzimidazoler, som er nyttige ved behandling af seksuel dysfunktion
ATE251117T1 (de) Neue aminobenzophenone
PT984936E (pt) Cianoguanidinas como inibidores da proliferacao celular
ATE274515T1 (de) Pyrazolopyridinderivate
UA93352C2 (ru) Производные замещенного индолилалкиламино kak ингибиторы гистондеацетилазы
MXPA06000988A (es) Derivados de nicotinamida utiles como inhibidores de pde4.
DE60014915D1 (de) Hypoxanthin- und thiohypxanthin-verbindungen